Skip to main content
. 2018 Feb 24;39(19):1709–1723. doi: 10.1093/eurheartj/ehy056

Table 1.

Clinical characteristics of patients with oral anticoagulation-ICH and mechanical heart valve who received sufficient oral anticoagulation reversal or insufficient oral anticoagulation reversal (n = 148)

Sufficient INR reversal (n = 37) Insufficient INR reversal (n = 111) P-value
Age (years), mean (±SD) 69 (59–75) 70 (62–76) 0.44
Female sex, n (%) 11 (29.7) 42 (37.8) 0.37
Pre-mRS, mean (±SD)a 0 (0–1) 0 (0–2) 0.38
Symptom onset–onset admission, (min), median (IQR) 125 (70–202) 129 (60–348) 0.73
Glasgow coma scale, median (IQR)b 9 (3–14) 14 (10–15) <0.01
Mechanical heart valve positions, n (%)
 Aortic valve 27 (73.0) 69 (62.2) 0.23
 Mitral valve 10 (27.0) 32 (28.8) 0.84
 Both locations 0 (0.0) 10 (9.0) 0.12
Imaging
 Deep ICH, n (%) 15 (40.5) 45 (40.5) 1.00
 Lobar ICH, n (%) 18 (48.6) 51 (45.9) 0.78
 Other ICH locations, n (%) 4 (5.4) 15 (9.0) 0.78
 ICH volume (mL), median (IQR) 28.1 (14.8–63.0) 19.4 (7.8–43.0) 0.05c
 Intraventricular haemorrhage, n (%) 23 (62.2) 40 (36.0) <0.01
Reversal treatment
 Admission reversal (min), median (IQR) 80 (54–120) 101 (60–235) 0.15
 Any reversal treatment, n (%) 37 (100.0) 109 (98.2) 1.00
 PCC, n (%) 37 (100.0) 99 (89.2) 0.07
  Dose (IU), median (IQR) 2500 (1800–3200) 2000 (1500–3000) 0.15
 FFP, n (%) 7 (18.9) 16 (14.4) 0.51
 Konakion, n (%) 31 (83.8) 84 (75.7) 0.31
Blood pressure control (mmHg), median (IQR)
 Initial systolic BP 162 (133–187) 156 (140–186) 0.85
 Initial diastolic BP 89 (72–98) 80 (70–99) 0.89
 Initial mean arterial BP 108 (89–127) 107 (96–127) 0.77
 Systolic BP (4 h) 141 (120–159) 141 (122–152) 0.99
 Diastolic BP (4 h) 65 (60–74) 70 (60–80) 0.31
 Mean arterial BP (4 h) 93 (79–101) 91 (83–103) 0.65
 Systolic BP (8 h) 133 (125–141) 132 (117–142) 0.41
 Diastolic BP (8 h) 68 (60–73) 65 (58–74) 0.63
 Mean arterial BP (8 h) 89 (83–98) 87 (80–96) 0.36
 Systolic BP (12 h) 127 (110–149) 135 (123–145) 0.22
 Diastolic BP (12 h) 60 (56–73) 66 (57–75) 0.43
 Mean arterial BP (12 h) 83 (75–100) 89 (80–96) 0.33
Coagulation parameters
 INR on admission, median (IQR) 2.83 (2.4.6–3.67) 2.70 (2.40–3.44) 0.27
 1st INR after reversal, median (IQR) 1.17 (1.11–1.22) 1.39 (1.27–1.60) <0.01
  INR <1.3 on 1st INR after reversal, n (%) 37 (100.0) 34 (30.6) <0.01
  INR <1.3 within 4 h, n (%) 37 (100.0) 0 (0.0) <0.01
 INR after 24 h, median (IQR) 1.26 (1.20–1.37) 1.27 (1.20–1.39) 0.64
 INR after 48 h, median (IQR) 1.24 (1.13–1.34) 1.26 (1.16–1.41) 0.41
 INR after 72 h, median (IQR) 1.23 (1.11–1.37) 1.25 (1.14–1.46) 0.33
Complications ≤72 h after ICH, n (%)
 Haemorrhagic complications
  Hematoma enlargement 6/30 (20) 49/100 (49) <0.01
  Other intracranial haemorrhage 1 (2.7) 0 (0.0) 0.25
  Extracranial haemorrhage 0 (0.0) 0 (0.0) 1.00
 Thromboembolic complication 0 (0.0) 0 (0.0) 1.00
Complications ≥72 h after ICH, n (%)
 Haemorrhagic complications 5 (13.5) 16 (14.4) 0.89
 Thromboembolic complication 2 (5.4) 6 (5.4) 1.00
Anticoagulation management
 Therapeutic Anticoagulation, n (%) 16 (43.2) 53 (47.7) 0.63
  Day after ICH, median (IQR) 7 (1–17) 4 (1–11) 0.89
  <72 h after ICH, n (%) 7 (18.9) 20 (18.0) 0.88

Significant parameters are presented in bold. Sufficient OAC reversal was defined as achieving INR values <1.3 within 4 h after admission.

ICH, intracerebral haemorrhage; INR, international normalized ratio; IQR, interquartile range; IU, international unit; mRS, modified Rankin Scale; SD, standard deviation.

a

Modified Rankin Scale range 0–6, from no disability to death.

b

Glasgow coma scale range 3–15, from deep coma to alert.

c

Not significant after Holm’s sequential Bonferroni correction.